China Universal Asset Management Company’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
22,961
-6
| -0% | -$567 | 0.2% | 99 |
|
|
2025
Q1 | $1.46M | Buy |
22,967
+119
| +0.5% | +$7.56K | 0.14% | 140 |
|
|
2024
Q4 | $1.06M | Buy |
22,848
+1,807
| +9% | +$83.9K | 0.1% | 156 |
|
|
2024
Q3 | $605K | Buy |
21,041
+5,691
| +37% | +$164K | 0.07% | 196 |
|
|
2024
Q2 | $222K | Sell |
15,350
-4,850
| -24% | -$70.1K | 0.03% | 226 |
|
|
2024
Q1 | $325K | Buy |
20,200
+5,322
| +36% | +$85.6K | 0.04% | 231 |
|
|
2023
Q4 | $296K | Sell |
14,878
-40,806
| -73% | -$811K | 0.06% | 177 |
|
|
2023
Q3 | $908K | Buy |
55,684
+34,811
| +167% | +$567K | 0.26% | 85 |
|
|
2023
Q2 | $441K | Buy |
20,873
+20,011
| +2,321% | +$423K | 0.14% | 111 |
|
|
2023
Q1 | $17.3K | Buy |
862
+245
| +40% | +$4.92K | 0.01% | 233 |
|
|
2022
Q4 | $16.1K | Buy |
+617
| New | +$16.1K | 0.01% | 188 |
|